» Articles » PMID: 36923118

Exploring the Common Pathogenesis of Alzheimer's Disease and Type 2 Diabetes Mellitus Microarray Data Analysis

Overview
Specialty Geriatrics
Date 2023 Mar 16
PMID 36923118
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Alzheimer's Disease (AD) and Type 2 Diabetes Mellitus (DM) have an increased incidence in modern society. Although more and more evidence has supported that DM is prone to AD, the interrelational mechanisms remain fully elucidated.

Purpose: The primary purpose of this study is to explore the shared pathophysiological mechanisms of AD and DM.

Methods: Download the expression matrix of AD and DM from the Gene Expression Omnibus (GEO) database with sequence numbers GSE97760 and GSE95849, respectively. The common differentially expressed genes (DEGs) were identified by limma package analysis. Then we analyzed the six kinds of module analysis: gene functional annotation, protein-protein interaction (PPI) network, potential drug screening, immune cell infiltration, hub genes identification and validation, and prediction of transcription factors (TFs).

Results: The subsequent analyses included 339 common DEGs, and the importance of immunity, hormone, cytokines, neurotransmitters, and insulin in these diseases was underscored by functional analysis. In addition, serotonergic synapse, ovarian steroidogenesis, estrogen signaling pathway, and regulation of lipolysis are closely related to both. DEGs were input into the CMap database to screen small molecule compounds with the potential to reverse AD and DM pathological functions. L-690488, exemestane, and BMS-345541 ranked top three among the screened small molecule compounds. Finally, 10 essential hub genes were identified using cytoHubba, including and . For the characteristic Aβ and Tau pathology of AD, was associated significantly positively with AD and significantly negatively with AD. In addition, we also found and significant correlations with DM phenotypes. Other datasets verified that , , and could be used as key markers of DM complicated with AD. Meanwhile, the immune cell infiltration score reflects the different cellular immune microenvironments of the two diseases.

Conclusion: The common pathogenesis of AD and DM was revealed in our research. These common pathways and hub genes directions for further exploration of the pathogenesis or treatment of these two diseases.

Citing Articles

Identifying Hub Genes and miRNAs Associated with Alzheimer's Disease: A Bioinformatics Pathway to Novel Therapeutic Strategies.

Gascon E, Calvo A, Molina N, Zaragoza P, Osta R Biomolecules. 2025; 14(12.

PMID: 39766348 PMC: 11726968. DOI: 10.3390/biom14121641.


Identification of the Shared Gene Signatures Between Alzheimer's Disease and Diabetes-Associated Cognitive Dysfunction by Bioinformatics Analysis Combined with Biological Experiment.

Chen Y, Ji X, Bao Z J Alzheimers Dis. 2024; 101(2):611-625.

PMID: 39213070 PMC: 11492114. DOI: 10.3233/JAD-240353.


Beneficial Effects of Echinacoside on Cognitive Impairment and Diabetes in Type 2 Diabetic db/db Mice.

Qin F, Yan Y, Yang N, Hao Y Exp Clin Endocrinol Diabetes. 2024; 132(8):420-430.

PMID: 38569512 PMC: 11324349. DOI: 10.1055/a-2298-4593.


A review and analysis of key biomarkers in Alzheimer's disease.

Zhang Z, Liu X, Zhang S, Song Z, Lu K, Yang W Front Neurosci. 2024; 18:1358998.

PMID: 38445255 PMC: 10912539. DOI: 10.3389/fnins.2024.1358998.


Network analysis-guided drug repurposing strategies targeting LPAR receptor in the interplay of COVID, Alzheimer's, and diabetes.

Malar D, Verma K, Prasanth M, Tencomnao T, Brimson J Sci Rep. 2024; 14(1):4328.

PMID: 38383841 PMC: 10882047. DOI: 10.1038/s41598-024-55013-9.

References
1.
Wirt R, Crew L, Ortiz A, McNeela A, Flores E, Kinney J . Altered theta rhythm and hippocampal-cortical interactions underlie working memory deficits in a hyperglycemia risk factor model of Alzheimer's disease. Commun Biol. 2021; 4(1):1036. PMC: 8417282. DOI: 10.1038/s42003-021-02558-4. View

2.
Abdul-Rahman O, Sasvari-Szekely M, Ver A, Rosta K, Szasz B, Kereszturi E . Altered gene expression profiles in the hippocampus and prefrontal cortex of type 2 diabetic rats. BMC Genomics. 2012; 13:81. PMC: 3299604. DOI: 10.1186/1471-2164-13-81. View

3.
Edgar R, Domrachev M, Lash A . Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2001; 30(1):207-10. PMC: 99122. DOI: 10.1093/nar/30.1.207. View

4.
Hollingworth P, Harold D, Sims R, Gerrish A, Lambert J, Carrasquillo M . Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet. 2011; 43(5):429-35. PMC: 3084173. DOI: 10.1038/ng.803. View

5.
Tanaka D, Nagashima K, Sasaki M, Funakoshi S, Kondo Y, Yasuda K . Exome sequencing identifies a new candidate mutation for susceptibility to diabetes in a family with highly aggregated type 2 diabetes. Mol Genet Metab. 2013; 109(1):112-7. DOI: 10.1016/j.ymgme.2013.02.010. View